Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ALR:US

48.5700 USD 0.0300 0.06%

As of 20:04:02 ET on 05/04/2015.

Snapshot for Alere Inc (ALR)

Open: 48.5100 Day's Range: 48.1600 - 48.8078 Volume: 396,314
Previous Close: 48.6000 52wk Range: 33.5000 - 50.6100 1-Yr Rtn: +36.82%

Stock Chart for ALR

No chart data available.
  • ALR:US 48.5700
  • 1D
  • 1M
  • 1Y
48.6000
Interactive ALR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 20.1786
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4649
Est. EPS (USD) (12/2015) 2.4070
Est. PEG Ratio 2.0179
Market Cap (M USD) 4,103.52
Shares Outstanding (M) 84.49
30 Day Average Volume 376,798
Price/Book (mrq) 3.2629
Price/Sale (ttm) 1.4093
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALR

Alere, Inc. offers patient diagnosis, monitoring and health management services. The Company produces consumer and professional medical diagnostic products, and remotely monitors patients for pre-eclampsia, and patients who are prescribed Warfarin for atrial fibrillation.

Namal NawanaPresident/CEO/COOJohn O'RourkeChief Information Officer
Avi PelossofGlobal Pres:Infectious DiseaseSanjay MalkaniGlobal President:Toxicology
More Company Profile & Key Executives for ALR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil